InflaRx (IFRX)
(Delayed Data from NSDQ)
$1.58 USD
+0.03 (1.94%)
Updated Nov 1, 2024 04:00 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
InflaRx N.V. (IFRX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$7.75 | $11.00 | $5.00 | 390.51% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for InflaRx N.V. comes to $7.75. The forecasts range from a low of $5.00 to a high of $11.00. The average price target represents an increase of 390.51% from the last closing price of $1.58.
Analyst Price Targets (4 )
Broker Rating
InflaRx N.V. currently has an average brokerage recommendation (ABR) of 1.40 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.40 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, four are Strong Buy, representing 80% of all recommendations. A month ago, Strong Buy represented 80%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.40 | 1.40 | 1.40 | 1.40 | 1.40 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/25/2024 | H.C. Wainwright & Co. | Edward White | Strong Buy | Strong Buy |
8/10/2024 | SVB Securities | Joseph P Schwartz | Strong Buy | Strong Buy |
8/8/2024 | Raymond James | Steven Seedhouse | Strong Buy | Strong Buy |
6/7/2024 | Guggenheim Securities | Yatin Suneja | Strong Buy | Strong Buy |
5/8/2024 | LifeSci Capital | Sam Slutsky | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.40 |
ABR (Last week) | 1.40 |
# of Recs in ABR | 5 |
Average Target Price | $7.75 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 89 of 252 |
Current Quarter EPS Est: | -0.27 |
IFRX FAQs
InflaRx N.V. (IFRX) currently has an average brokerage recommendation (ABR) of 1.40 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 5 brokerage firms.
The average price target for InflaRx N.V. (IFRX) is $7.75. The current on short-term price targets is based on 3 reports.
The forecasts for InflaRx N.V. (IFRX) range from a low of $5 to a high of $11. The average price target represents a increase of $390.51 from the last closing price of $1.58.
The current UPSIDE for InflaRx N.V. (IFRX) is 390.51%
Based on short-term price targets offered by four analysts, the average price target for InflaRx N.V. comes to $7.75. The forecasts range from a low of $5.00 to a high of $11.00. The average price target represents an increase of 390.51% from the last closing price of $1.58.